Pyogenic granuloma

L12_PYOGENGRANUL

Hodgkins lymphoma: Hodgkin lymphoma (HL) is a heterogeneous group of malignant lymphoid neoplasms of B-cell origin characterized histologically by the presence of Hodgkin and Reed-Sternberg (HRS) cells in the vast majority of cases. There are two distinct subtypes: nodular lymphocyte predominant Hodgkin lymphoma and classical Hodgkin lymphoma. Hodgkin lymphoma involves primarily lymph nodes.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 L98.0

Hospital discharge: ICD-9 6861

Hospital discharge: ICD-8 68610

Cause of death: ICD-10 L98.0

Cause of death: ICD-9 6861

Cause of death: ICD-8 68610

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

Check minimum number of events None

Include endpoints None

318

L12_PYOGENGRANUL

Extra metadata

Level in the ICD hierarchy 4

First used in FinnGen datafreeze DF2

Parent code in ICD-10 L98

Name in latin Granuloma pyogenicum

Similar endpoints

↥

List of similar endpoints to Pyogenic granuloma based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	308	175	133
Unadjusted prevalence (%)	0.10	0.10	0.10
Mean age at first event (years)	50.90	48.85	53.60

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: L12_PYOGENGRANUL – Pyogenic granuloma
GWS hits: 0

Survival analyses between endpoints

↥

Plot

before Pyogenic granuloma
after Pyogenic granuloma

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Pyogenic granuloma

↥